Amneal Pharmaceuticals (AMRX) EBIT Growth (5y) (2022 - 2026)
Amneal Pharmaceuticals (AMRX) EBIT Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.71 Bn | 5.58 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.09% |
| Mar 31, 2026 | 25.30% |
| Dec 31, 2025 | 40.89% |
| Sep 30, 2025 | 95.95% |
| Jun 30, 2025 | 59.61% |
| Mar 31, 2025 | 11.67% |
| Dec 31, 2024 | 39.46% |
| Sep 30, 2024 | 22.79% |
| Jun 30, 2024 | 47.78% |
| Mar 31, 2024 | 35.24% |
| Dec 31, 2023 | -9.42% |
| Sep 30, 2023 | 0.29% |
| Jun 30, 2023 | 19.55% |
| Mar 31, 2023 | -11.53% |
| Dec 31, 2022 | 11.81% |
| Sep 30, 2022 | -10.85% |
| Jun 30, 2022 | -45.20% |